Rapid Therapeutic Science Laboratories, Inc. (RTSL)
USD 0.0
(2.56%)
USD 0.0
(2.56%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 5.39 Million USD | 50.66% |
| 2021 | 3.58 Million USD | 0.0% |
| 2019 | 3.16 Million USD | 0.0% |
| 2017 | 2.88 Million USD | 9434.3% |
| 2016 | 30.3 Thousand USD | 168.69% |
| 2015 | 11.27 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 4.87 Million USD | -9.71% |
| 2023 Q2 | 4.81 Million USD | -1.2% |
| 2022 Q4 | 5.39 Million USD | 0.43% |
| 2022 FY | 5.39 Million USD | 50.66% |
| 2022 Q2 | 5.34 Million USD | -5.04% |
| 2022 Q1 | 5.63 Million USD | 57.27% |
| 2022 Q3 | 5.37 Million USD | 0.45% |
| 2021 Q4 | 3.58 Million USD | 63.14% |
| 2021 Q3 | 2.19 Million USD | 256.11% |
| 2021 Q2 | 616.51 Thousand USD | 121.58% |
| 2021 Q1 | 278.23 Thousand USD | 0.0% |
| 2021 FY | 3.58 Million USD | 0.0% |
| 2020 Q1 | 1.8 Million USD | 7.62% |
| 2020 Q3 | 1.29 Million USD | -30.7% |
| 2020 Q2 | 1.87 Million USD | 3.4% |
| 2019 FY | 3.16 Million USD | 0.0% |
| 2019 Q2 | 3.22 Million USD | 1.88% |
| 2019 Q1 | 3.16 Million USD | 1.51% |
| 2019 Q4 | 1.68 Million USD | -48.86% |
| 2019 Q3 | 3.28 Million USD | 1.79% |
| 2018 Q3 | 3.05 Million USD | 1.97% |
| 2018 Q1 | 2.88 Million USD | 0.0% |
| 2018 Q2 | 2.99 Million USD | 3.55% |
| 2018 Q4 | 3.12 Million USD | 2.37% |
| 2017 FY | 2.88 Million USD | 9434.3% |
| 2017 Q3 | 35.3 Thousand USD | 9.89% |
| 2017 Q4 | - USD | -100.0% |
| 2017 Q2 | 32.12 Thousand USD | 6.02% |
| 2017 Q1 | 30.3 Thousand USD | 46.02% |
| 2016 Q2 | 10.75 Thousand USD | -4.67% |
| 2016 FY | 30.3 Thousand USD | 168.69% |
| 2016 Q1 | 11.27 Thousand USD | 0.0% |
| 2016 Q4 | 20.75 Thousand USD | -7.78% |
| 2016 Q3 | 22.5 Thousand USD | 109.3% |
| 2015 Q2 | 1423.00 USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | 11.27 Thousand USD | 0.0% |
| 2015 Q3 | - USD | -100.0% |
| 2014 Q4 | - USD | -100.0% |
| 2014 Q2 | 4046.00 USD | 0.0% |
| 2014 Q3 | 5546.00 USD | 37.07% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | 53.456% |
| BioElectronics Corporation | 16.62 Million USD | 67.538% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -751.114% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -696.331% |
| Polarean Imaging plc | 2.58 Million USD | -109.106% |
| AVITA Medical, Inc. | 19.86 Million USD | 72.837% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -154.772% |
| Össur hf. | 688.8 Million USD | 99.217% |
| Zecotek Photonics Inc. | 5.86 Million USD | 8.052% |
| QHSLab, Inc. | 2.05 Million USD | -162.321% |
| Wellstar International, Inc. | 55.99 Million USD | 90.363% |
| Össur hf. | 688.8 Million USD | 99.217% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 66.444% |
| Escalon Medical Corp. | 2.94 Million USD | -83.02% |
| Aurora Spine Corporation | 6.65 Million USD | 18.899% |
| BrainsWay Ltd. | 15.31 Million USD | 64.764% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 10.255% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 88.229% |
| Vivos Inc. | 245 Thousand USD | -2102.439% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.783% |
| Kelyniam Global, Inc. | 1.01 Million USD | -432.716% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -1857.833% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -120.265% |
| Nanomix Corporation | 14.81 Million USD | 63.576% |
| Theraclion SA | 13.01 Million EUR | 58.545% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -5.306% |
| Positron Corporation | 2.02 Million USD | -166.341% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -49.014% |
| Lombard Medical, Inc. | 53.79 Million USD | 89.969% |
| ALR Technologies Inc. | 24.5 Million USD | 77.98% |
| Stratec SE | 271.97 Million USD | 98.016% |
| Vycor Medical, Inc. | 4.31 Million USD | -24.973% |
| Heart Tronics, Inc. | 1.09 Million USD | -392.886% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -128.764% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 1.47% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 91.774% |
| VMS Rehab Systems, Inc. | 201.36 USD | -2679708.8% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 1.442% |
| Ingen Technologies, Inc. | 5.7 Million USD | 5.491% |
| Odyssey Group International, Inc. | 6.61 Million USD | 18.386% |
| United American Healthcare Corporation | 119 Thousand USD | -4434.507% |
| ECGI Holdings, Inc. | 11.94 Million USD | 54.808% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -307.563% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -273.085% |
| Urologix, Inc. | 12.64 Million USD | 57.323% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 36.386% |
| SS Innovations International, Inc. | 11.18 Million USD | 51.739% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -927.064% |
| Smith & Nephew plc | 4.76 Billion USD | 99.887% |
| NIOX Group Plc | 9.8 Million USD | 44.95% |
| Fuse Medical, Inc. | 15.11 Million USD | 64.288% |
| Broncus Holding Corporation | 10.43 Million USD | 48.275% |
| Brain Scientific Inc. | 7.42 Million USD | 27.339% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 84.037% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -579.536% |